Laboratory of targeted gene mapping for predictive oncological diagnostics of Czech Center Digital Genomics (Q11526): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The TGM project aims at creating a new dedicated human genome mapping site for collaborative development and clinical research on new products for determining the early stages of cancer involving circulating blood cells. We are planning to make a major contribution to the development of the Thanotics in the Czech Republic, i.e. diagnostics based on diagnostics that lead to the personalisation of health care, efficiency gains and targeted thera...) |
(Created claim: summary (P836): The aim of the TGM project is to create a new workplace for targeted mapping of the human genome, which will serve for collaborative development and clinical research of new products for the determination of early stages of cancer using circulating cells from blood. We plan to make a major contribution to the development of Theranostka in the Czech Republic, i.e. diagnostic therapy, which leads to personalisation of health care, increased effici...) |
||||||||||||||
| Property / summary | |||||||||||||||
The aim of the TGM project is to create a new workplace for targeted mapping of the human genome, which will serve for collaborative development and clinical research of new products for the determination of early stages of cancer using circulating cells from blood. We plan to make a major contribution to the development of Theranostka in the Czech Republic, i.e. diagnostic therapy, which leads to personalisation of health care, increased efficiency and targeted therapy and significantly reduces medical costs. a. (English) | |||||||||||||||
| Property / summary: The aim of the TGM project is to create a new workplace for targeted mapping of the human genome, which will serve for collaborative development and clinical research of new products for the determination of early stages of cancer using circulating cells from blood. We plan to make a major contribution to the development of Theranostka in the Czech Republic, i.e. diagnostic therapy, which leads to personalisation of health care, increased efficiency and targeted therapy and significantly reduces medical costs. a. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The aim of the TGM project is to create a new workplace for targeted mapping of the human genome, which will serve for collaborative development and clinical research of new products for the determination of early stages of cancer using circulating cells from blood. We plan to make a major contribution to the development of Theranostka in the Czech Republic, i.e. diagnostic therapy, which leads to personalisation of health care, increased efficiency and targeted therapy and significantly reduces medical costs. a. (English) / qualifier | |||||||||||||||
point in time: 22 October 2020
| |||||||||||||||
Revision as of 15:09, 22 October 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Laboratory of targeted gene mapping for predictive oncological diagnostics of Czech Center Digital Genomics |
Project in Czech Republic financed by DG Regio |
Statements
25,300,500.0 Czech koruna
0 references
50,601,000.0 Czech koruna
0 references
50 percent
0 references
31 March 2020
0 references
Institute of Applied Biotechnologies a.s.
0 references
50°5'1.93"N, 14°30'28.48"E
0 references
10800
0 references
10800
0 references
Záměrem projektu TGM je vytvoření nového pracoviště pro cílené mapování lidského genomu, které bude sloužit k kolaborativnímu vývoji a klinickému výzkumu nových produktů pro stanovení ranných stádií rakoviny s využitím cirkulujících buněk z krve. Plánujeme zásadním způsobem přispět k rozvoji Theranostiky v ČR, tedy terapie založené na diagnostice, která vede k personalizaci zdravotní péče, zvýšení efektivity a cílené terapie a výrazně snižuje léčebné náklady. a. (Czech)
0 references
The aim of the TGM project is to create a new workplace for targeted mapping of the human genome, which will serve for collaborative development and clinical research of new products for the determination of early stages of cancer using circulating cells from blood. We plan to make a major contribution to the development of Theranostka in the Czech Republic, i.e. diagnostic therapy, which leads to personalisation of health care, increased efficiency and targeted therapy and significantly reduces medical costs. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_093/0012409
0 references